- Home
- LNC vs KYMR Comparison
LNC vs KYMR Comparison
Compare LNC & KYMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | LNC | KYMR |
|---|---|---|
| Founded | 1905 | 2015 |
| Country | United States | United States |
| Employees | 9423 | N/A |
| Industry | Life Insurance | Medicinal Chemicals and Botanical Products |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.8B |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | LNC | KYMR |
|---|---|---|
| Price | $37.61 | $81.79 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 16 | 26 |
| Target Price | $43.13 | ★ $107.72 |
| AVG Volume (30 Days) | ★ 1.4M | 438.2K |
| Earning Date | 05-07-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.87% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $39,211,000.00 |
| Revenue This Year | $9.60 | $10.61 |
| Revenue Next Year | $3.73 | $8.17 |
| P/E Ratio | $7.17 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $31.61 | $28.06 |
| 52 Week High | $46.82 | $103.00 |
Technical Indicators
Market Signals| Indicator | LNC | KYMR |
|---|---|---|
| Relative Strength Index (RSI) | 57.51 | 46.16 |
| Support Level | $33.84 | $77.78 |
| Resistance Level | $42.08 | $90.15 |
| Average True Range (ATR) | 0.96 | 3.85 |
| MACD | 0.09 | -0.70 |
| Stochastic Oscillator | 64.67 | 40.51 |
Price Performance
Historical ComparisonAbout LNC Lincoln National Corporation
Lincoln National Corp operates multiple insurance and retirement businesses. The company's operating segment includes Annuities; Retirement Plan Services; Life Insurance and Group Protection. Its products include fixed and indexed annuities, variable annuities, universal life insurance (UL), variable universal life insurance (VUL), linked-benefit UL and VUL, indexed universal life insurance (IUL), term life insurance, employer-sponsored retirement plans and services, and group life, disability, and dental.
About KYMR Kymera Therapeutics Inc.
Kymera Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to reinventing the treatment of human disease through the development of differentiated medicines that address health problems and meaningfully improve patients' lives. It is committed to novel technologies to address targets that have known disease-causing biology, but which have not been drugged, or have been inadequately drugged, often based on limitations of existing technologies. Its approach is intended to discover and develop a new generation of medicines in a disease-agnostic manner. Its product pipelines are STAT6, TYK2, and IRAK4.